<DOC>
	<DOCNO>NCT01647906</DOCNO>
	<brief_summary>The purpose observational study evaluate safety effectiveness Solesta Injectable Bulking Agent treatment fecal incontinence 3 year real world setting .</brief_summary>
	<brief_title>Long Term Safety Efficacy SolestaÂ® Injectable Bulking Agent Treatment Fecal Incontinence ( SoFI )</brief_title>
	<detailed_description />
	<mesh_term>Fecal Incontinence</mesh_term>
	<criteria>A patient eligible study participation he/she meet follow criterion : Able fluently speak understand language study conduct able provide meaningful write informed consent study . Have FI , fail conservative therapy ( e.g. , diet , fiber therapy , medication treat diarrhea ) , schedule receive Solesta treatment . Females must nonchildbearing potential ; female childbearing ( reproductive ) potential must agree use acceptable method contraception least first 6 month study participation negative urine pregnancy test Visit 1 ( Screening/Baseline ) immediately prior receive initial Solesta treatment . Women surgically sterile post menopausal least 2 year prior enter study consider childbearing potential . Willing return study facility post treatment evaluation . A patient exclude study he/she meet follow criterion : Is currently pregnant , breastfeeding , plan become pregnant course study . Has active inflammatory bowel disease . Has immunodeficiency disorder ongoing immunosuppressive therapy . Has receive previous radiation treatment pelvic area . Has significant mucosal full thickness rectal prolapse . Has active anorectal condition include : abscess , fissure , sepsis , bleeding , proctitis , infection . Has anorectal atresia , tumor , stenosis malformation . Has rectocele . Has rectal varix . Has presence exist implant include Solesta , artificial bowel sphincter , sacral nerve stimulator ( activate inactivate ) . Has allergy hyaluronic acid ( HA ) base product . Has anastomosis rectum anus within 10 cm dentate line . Has unstable condition ( e.g. , psychiatric disorder , recent history substance abuse ) otherwise think unreliable incapable complying requirement postapproval study protocol . Has disorder , opinion Investigator , might interfere conduct study . Has undergone sphincteroplasty , graciloplasty , surgical intervention ( without use implanted device ) treatment fecal incontinence within 12 month enrollment . Has bleed disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>